The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas

Por Aune, Guro, Stunes, Astrid K, Tingulstad, Solveig, Salvesen, Øyvind, Syversen, Unni, Torp, Sverre H
Publicado em 2011

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

Por Nordsletten Lars, Obrant Karl J, Gustafsson Björn I, Stunes Astrid K, Syversen Unni, Berge Rolf, Thommesen Liv, Reseland Janne E
Publicado em 2009-03-01

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone

Por Syversen, Unni, Stunes, Astrid K, Gustafsson, Björn I, Obrant, Karl J, Nordsletten, Lars, Berge, Rolf, Thommesen, Liv, Reseland, Janne E
Publicado em 2009

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomi...

Por Stunes, Astrid K, Westbroek, Irene, Gustafsson, Björn I, Fossmark, Reidar, Waarsing, Jan H, Eriksen, Erik F, Petzold, Christiane, Reseland, Janne E, Syversen, Unni
Publicado em 2011